What is APMD's P/E ratio?

Apnimed, Inc. Common Stock (APMD) currently trades at a P/E ratio of 13.50.

Apnimed, Inc. Common Stock reports a Return on Equity (ROE) of 16.20%.

What is APMD's dividend yield?

Apnimed, Inc. Common Stock offers a dividend yield of 0.00%.

What is APMD's Quality Score?

Our AI rates APMD's overall financial quality at 69 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy APMD?

Our AI Timing Score for APMD is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does APMD belong to?

Apnimed, Inc. Common Stock is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Apnimed, Inc. (APMD) Stock Price, Quality Score & AI Analysis

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-03 | FS: 2026-03-31)

APMD AI Analysis Summary

Our AI summary for APMD: Apnimed, Inc. Common Stock (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 13.50, ROE of 16.20%, a dividend yield of 0.00%. Its financial Quality Score stands at 69/100 — mid-range fundamentals relative to the market. The AI Timing Score is 0/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

APMD

Apnimed, Inc. Common Stock

US:NASDAQ STOCK Healthcare >> Biotechnology

USD 25.00

0.00 (0.00%) Day Change

Watchlist Portfolio Compare Chart

13.50

P/E

0.18

D/E

16.2%

ROE

12.2%

ROA

0.00%

Div Yield

APNIMED, INC. COMMON STOCK
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 25.00 Price 0.00 (0.00%) Day Change	NEWS SCORE: N/A

APMD, the overall quality is ok ( Quality = 69) and the timing to buy is ...(Sign In to See)...

No price data to display chart for the last 3-months of this stock

69 QUALITY

Signal: NEUTRAL

Signal Description: Company financial health is OK

Reason: Negative growth of ROE in the last year.
Acceleration of ROA growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...

Quality Factors

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	25.00
PBV / Sector	3.69 / 44,219.29
Earning Per Share	1.10

PE / Sector	13.50 / 19.28
PEG or PE/Growth / Sector	N/A / 1.23
Average 1M Daily Value	51.62 M
Average 1W Daily Value	51.62 M

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

64%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	47.45 / 98.22 GREAT
NPM Average (%) / Sector	-448.07 / -1,697.63
NPM Change Average (%) / Sector	-1,079.06 / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	12.18 / 185,260.96
ROA Average (%) / Sector	-30.34 / 36,684.70
ROA Change Average (%) / Sector	-575.48 / 422,221.66
ROE (%) / Sector	16.20 / 243,762.23
ROE Average (%) / Sector	20.41 / 48,758.47 GOOD
ROE Change Average (%) / Sector	3,139.93 / 424,968.10 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.19

Registration Details

Analyze Date	2026-08-04 08:01:09
Symbol	APMD
Name	APNIMED, INC. COMMON STOCK
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	38.00 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	949.99 / 9,645.64

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 39 John F. Kennedy Street, Cambridge, MA, United States, 02138

Phone: (617) 500-8880

Website: https://apnimed.com

Employees: 65

Sector: Healthcare >> Biotechnology

Description: Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.